317 related articles for article (PubMed ID: 12746793)
21. d4T and lactic acidosis with neuromuscular weakness: FDA warning.
AIDS Treat News; 2002 Mar; (378):5-6. PubMed ID: 11965919
[No Abstract] [Full Text] [Related]
22. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
23. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
Calza L; Manfredi R; Chiodo F
Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
[TBL] [Abstract][Full Text] [Related]
25. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.
Currier JS
Clin Infect Dis; 2007 Jul; 45(2):261-2. PubMed ID: 17578789
[No Abstract] [Full Text] [Related]
27. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
28. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
McComsey G
AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
[TBL] [Abstract][Full Text] [Related]
29. Lactic acidosis in HIV infected children due to antiretroviral therapy.
Shah I
Indian Pediatr; 2005 Oct; 42(10):1051-2. PubMed ID: 16269849
[No Abstract] [Full Text] [Related]
30. Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.
Posteraro AF; Mauriello M; Winter SM
Conn Med; 2001 Jul; 65(7):387-90. PubMed ID: 11508132
[TBL] [Abstract][Full Text] [Related]
31. HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barré syndrome.
Wooltorton E
CMAJ; 2002 Apr; 166(8):1067. PubMed ID: 12002986
[No Abstract] [Full Text] [Related]
32. Case report: nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy.
Mandelbrot L; Kermarrec N; Marcollet A; Lafanechère A; Longuet P; Chosidow D; Saada M
AIDS; 2003 Jan; 17(2):272-3. PubMed ID: 12545093
[No Abstract] [Full Text] [Related]
33. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
[TBL] [Abstract][Full Text] [Related]
34. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
[TBL] [Abstract][Full Text] [Related]
35. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Viganò A; Giacomet V
Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
[No Abstract] [Full Text] [Related]
36. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
[TBL] [Abstract][Full Text] [Related]
37. Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment.
Cornejo-Juárez P; Sierra-Madero J; Volkow-Fernández P
Arch Med Res; 2003; 34(1):64-9. PubMed ID: 12604378
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of mitochondrial toxicity.
Walker UA
J HIV Ther; 2001 Mar; 6(1):17-21. PubMed ID: 11501197
[No Abstract] [Full Text] [Related]
39. Lactic acidosis in HIV patients receiving highly active antiretroviral therapy.
Chow YW; Leong CL; Chow HL; Hooi LS
Med J Malaysia; 2007 Mar; 62(1):78-80. PubMed ID: 17682581
[TBL] [Abstract][Full Text] [Related]
40. Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors.
Boffito M; Marietti G; Audagnotto S; Raiter R; Di Perri G
Clin Infect Dis; 2002 Feb; 34(4):558-9. PubMed ID: 11797190
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
